Plasma concentrations of adrenomedullin and ghrelin in hemodialysis patients with sustained and episodic hypotension

Endocrine Journal

Volumn 52, Issue 1, 2005, Pages 23-28

  Iwanaga, Kikuko ^a   Takamura, Noboru ^a   Abe, Yasuyo ^a   Zhaojia, Ye ^a   Shinzato, Ken ^b   Hosoda, Hiroshi ^c   Kangawa, Kenji ^c   Ohtsuru, Akira ^d   Kohno, Shigeru ^a   Yamashita, Shunichi ^a   Aoyagi, Kiyoshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Shinzato Nephro Clinic   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d Takashi Nagai Mem Intl H   (Japan)

Author keywords

Adrenomedullin; Chronic hypotension; Episodic hypotension; Ghrelin; Hemodialysis; Sustained hypotension

Indexed keywords

ADRENOMEDULLIN; GHRELIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; EPISODIC HYPOTENSION; FEMALE; HEMODIALYSIS; HORMONE BLOOD LEVEL; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; SUSTAINED HYPOTENSION;

ADRENOMEDULLIN; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PEPTIDE HORMONES; PEPTIDES; RENAL DIALYSIS; VASODILATOR AGENTS;

EID: 20144369606     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.52.23     Document Type: Article

References (29)

1. Cases A, Coll E (2002) Chronic hypotension in the dialysis patient. J Nephrol 15: 331-335.
2. Victor RG, Henrich WL (1994) Autonomic neuropathy and hemodynamic stability in end-stage renal disease patients. In: Heinrich WL (ed) Principles and Practice of Dialysis. Williams & Wilkins, Baltimore, 196-208.
3. Henrich WL (1999) Hemodynamic instability during dialysis and cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis 33: XLIX-LII.
4. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192: 553-560.
5. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T (1993) Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 194: 720-725.
6. Cases A, Esforzado N, Lario S, Vera M, Lopez-Pedret J, Rivera-Fillat F, Jimenez W (2000) Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension. Kidney Int 57: 664-670.
7. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660.
8. Mori K, Yoshimoto A, Takaya K, Hosoda K, Ariyasu H, Yahata K, Mukoyama M, Sugawara A, Hosoda H, Kojima M, Kangawa K, Nakao K (2000) Kidney produces a novel acylated peptide, ghrelin. FEBS Lett 486: 213-216.
9. Hosoda H, Kojima M, Matsuo H, Kangawa K (2000) Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 279: 909-913.
10. Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, Hayashi Y, Kangawa K (2001) Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280: R1483-1487.
11. Hosoda H, Kojima M, Kangawa K (2002) Ghrelin and the regulation of food intake and energy balance. Mol Interv 2: 494-503.
12. Wiley KE, Davenport AP (2002) Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 136: 1146-1152.
13. Keshaviah P, Shapiro FL (1982) A critical examination of dialysis-induced hypotension. Am J Kidney Dis 1982; 2: 290-301.
14. Imai Y, Abe K, Otsuka Y, Sato M, Haruyama T, Ito T, Omata K, Yoshinaga K, Sekino H (1981) Blood pressure regulation in chronic hypotensive and hypertensive patients with chronic renal failure. Jap Circ J 45: 303-314.
15. Armengol NE, Cases Amenos A, Bono Illa M, Calls Ginesta J, Gaya Bertran J, Rivera Fillat FR (1997) Vasoactive hormones in ureamic patients with chronic hypotension. Nephrol Dial Transplant 12: 321-324.
16. Tajiri M (1993) A clinical study of persistent hypotension in patients on chronic hemodialysis. Nippon Jinzo Gakkai Shi 35: 223-231.
17. Guieu R, Brunet P, Sampol J, Bechis G, Fenouillet E, Mege JL, Capo C, Vitte J, Ibrahim Z, Carrega L, Lerda D, Rochat H, Berland Y, Dussol B (2001) Adenosine and hemodialysis in humans. J Investig Med 49: 56-67.
18. Tokura T, Kinoshita H, Fujimoto S, Hisanaga S, Kitamura K, Eto T (2001) Plasma levels of mature form of adrenomedullin in patients with hemodialysis. Nephrol Dial Transplant 16: 783-786.
19. Kaysen GA (2001) The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 12: 1549-1557.
20. Nishimura M, Ushiyama M, Maruyama Y, Mabuchi H, Takahashi H, Yoshimura M (2000) Association of human hepatocyte growth factor with hemodialysis hypotension. Hypertens Res 23: 581-586.
21. Malatino LS, Mallamaci F, Benedetto FA, Bellanuova I, Cataliotti A, Tripepi G, Zoccali C (2000) Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. Am J Kidney Dis 36: 945-952.
22. Sugimura K, Lee CC, Kim T, Goto T, Kasai S, Harimoto K, Yamagami S, Kishimoto T (1997) Production of hepatocyte growth factor is increased in chronic renal failure. Nephron 75: 7-12.
23. Kanozawa K, Shimosawa T, Nagasawa R, Matsuda A, Kato H, Matsumura O, Mitarai T, Isoda K, Fujita T (2002) Mature form of adrenomedullin is a useful marker to evaluate blood volume in hemodialysis patients. Am J Kidney Dis 40: 794-801.
24. Yoshimoto A, Mori K, Sugawara A (2002) Plasma ghrelin and desacyl ghrelin concentration in renal failure. J Am Soc Nephrol 13: 2748-2752.
25. Kojima M, Hosoda H, Matsuo H, Kangawa K (2001) Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 12: 118-122.
26. Mori K, Yoshimoto A, Takaya K (2000) Kidney produces a novel acylated peptide, ghrelin. FEBS Lett 486: 213-216.
27. Ayala E, Pecoits-Frlho R, Heimburger O (2004) Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant 19: 421-426.
28. Lin SH, Chu P, Yu FC, Diang LK, Lin YF (1996) Increased nitric oxide production in hypotensive hemodialysis patients. ASAIO J 42: M895-899.
29. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA (2001) Autonomic neuropathy is linked to nocturnal hypoxaemia and to concentric hypertrophy and remodelling in dialysis patients. Nephrol Dial Transplant 16: 70-777.